Tetracycline-Guided Debridement and Cone Beam Computed Tomography for the Treatment of Bisphosphonate-Related Osteonecrosis of the Jaw: A Technical Note

Journal of Oral and Maxillofacial Surgery

Volumn 66, Issue 12, 2008, Pages 2646-2653

  Fleisher, Kenneth E ^a   Doty, Steven ^b   Kottal, Shailesh ^c   Phelan, Joan ^c   Norman, Robert G ^a   Glickman, Robert S ^a  

^a NEW YORK UNIVERSITY COLLEGE OF DENTISTRY   (United States)

^b HOSPITAL FOR SPECIAL SURGERY   (United States)

^c Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; AMOXICILLIN PLUS CLAVULANIC ACID; BISPHOSPHONIC ACID DERIVATIVE; CLINDAMYCIN; ETIDRONIC ACID; PAMIDRONIC ACID; TETRACYCLINE; ZOLEDRONIC ACID;

ARTICLE; BONE NECROSIS; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DEBRIDEMENT; HUMAN; HYPOCALCEMIA; INFECTION; JAW DISEASE; MYELOMA; NEOPLASM; OSTEOPOROSIS; PAGET BONE DISEASE;

BONE DENSITY CONSERVATION AGENTS; CONE-BEAM COMPUTED TOMOGRAPHY; DIPHOSPHONATES; FLUORESCENT DYES; HUMANS; JAW DISEASES; OSTEONECROSIS; TETRACYCLINE;

EID: 56149102174     PISSN: 02782391     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joms.2008.07.021     Document Type: Article

References (42)

1. Mauck K., and Clarke B. Diagnosis, screening, prevention, and treatment of osteoporosis. Mayo Clin Proc 81 (2006) 662
2. Stewart A. Clinical practice. Hypercalcemia associated with cancer. N Engl J Med 352 (2005) 373
3. Whyte M. Clinical practice. Paget's disease of bone. N Engl J Med 355 (2006) 593
4. Berenson J. Recommendations for Zoledronic acid treatment of patients with bone metastases. Oncologist 10 (2005) 52
5. Shipman C., Rogers M., Apperley J., et al. Bisphosphonates induce apoptosis in human myeloma cell lines: A novel anti-tumor activity. Br J Haematol 98 (1997) 665
6. Senaratne S., Pirianov G., Mansi J.L., et al. Bisphosphonates induce apoptosis in human breast cancer cell lines. Br J Cancer 82 (2000) 1459
7. Wood J., Bonjean K., Ruetz S., et al. Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid. J Pharmacol Exp Ther 302 (2002) 1055
8. Gnant M., Mlineritsch B., Schippinger W., et al. Adjuvant ovarian suppression combined with tamoxifen or anastrozole, alone or in combination with zoledronic acid, in premenopausal women with hormone-responsive, stage I and II breast cancer: First efficacy results from ABCSG-12 [Abstract]. J Clin Oncol 26 Suppl (2008) LBA4
9. Dannemann C., Gratz K., Riener M., et al. Jaw osteonecrosis related to bisphosphonate therapy: A severe secondary disorder. Bone 40 (2007) 828
10. Stafford R., Drieling R., and Hersh A. National trends in osteoporosis visits and osteoporosis treatment. Arch Intern Med 164 (2004) 1525
11. Zervas K., Verrou E., Teleioudis Z., et al. Incidence, risk factors and management of osteonecrosis of the jaw in patients with multiple myeloma: A single center experience in 303 patients. Br J Haematol 134 (2006) 620
12. Zavras A., and Zhu S. Bisphosphonates are associated with increased risk for jaw surgery in medical claims data: Is it osteonecrosis?. J Oral Maxillofac Surg 64 (2006) 917
13. Hoff A., Toth B., Altundag K., et al. Osteonecrosis of the jaw in patients receiving intravenous bisphosphonate therapy [Abstract]. J Clin Oncol 24 18S (2006) 8528
14. Bamias A., Kastritis E., Bamia C., et al. Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors. J Clin Oncol 23 (2005) 8580
15. Durie B., Katz M., and Crowley J. Osteonecrosis of the jaw and bisphosphonates. New Engl J Med 353 (2005) 99
16. Mavrokokki T., Cheng A., Stein B., et al. Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia. J Oral Maxillofac Surg 65 (2007) 415
17. Bertoldo F., Santini D., and Lo Cascio V. Bisphosphonates and osteomyelitis of the jaw: A patholgenic puzzle. Nat Clin Pract Oncol 4 (2007) 711
18. Ruggiero S., Gralow J., Marx R., et al. Practical guidelines for the prevention, diagnosis, and treatment of osteonecrosis of the jaw in patients with cancer. J Oncol Pract 2 (2006) 7
19. Marx R. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: A growing epidemic. J Oral Maxillofac Surg 61 (2003) 1115
20. Van den Wyngaert T., Huizing M., and Vermorken J. Bisphosphonates and osteonecrosis of the jaw: Cause and effect or a post hoc fallacy?. Ann Oncol 17 (2006) 1197
21. Ficarra G., Beninati F., Rubino I., et al. Osteonecrosis of the jaws in periodontal patients with a history of bisphosphonates treatment. J Clin Periodontol 32 (2005) 1123
22. Melo M., and Obeid G. Osteonecrosis of the jaws in patients with a history of receiving bisphosphonate therapy. JADA 136 (2005) 1675
23. Mignogna M., Fedele S., Lo Russo L., et al. Case 2. Osteonecrosis of the jaws associated with bisphosphonate therapy. J Clin Oncol 24 (2006) 1475
24. Marx R., Sawatari Y., Fortin M., et al. Bisphosphonate-induced exposed bone (osteonecrosisi/osteopetrosis) of the jaws: Risk factors, recognition, prevention, and treatment. J Oral Maxillofac Surg 63 (2005) 1567
25. Markiewicz M., Margarone J., Campbell J., et al. Bisphosphonate-associated osteonecrosis of the jaws. JADA 136 (2006) 1669
26. Groetz K., and Al-Nawas B. Persisting alveolar sockets-A radiologic symptom of BP-ONJ?. J Oral Maxillofac Surg 64 (2006) 1571
27. Marx R., Cillo J., and Ulloa J. Oral bisphosphonate-induced osteonecrosis: Risk factors, prediction of risk using serum CTX testing, prevention, and treatment. J Oral Maxillofac Surg 65 (2007) 2397
28. Migliorati C., Siegel M., and Elting L. Bisphosphonate-associated osteonecrosis: A long-term complication of bisphosphonate treatment. Lancet Oncol 7 (2006) 508
29. Melo M., and Obeid G. Osteonecrosis of the maxilla in a patient with a history of bisphosphonate therapy. J Can Dent Assoc 71 (2005) 111
30. Engroff S., and Kim D. Treating bisphosponate osteonecrosis of the jaws: Is there a role for resection and vascularized reconstruction?. J Oral Maxillofac Surg 65 (2007) 2374
31. Advisory Task Force on Bisphosphonate-Related Osteonecrosis of the Jaws. American Association of Oral and Maxillofacial Surgeons Position Paper on Bisphosphonate-Related Osteonecrosis of the Jaws. J Oral Maxillofac Surg 65 (2007) 369
32. Ruggiero S., Mehrotra B., Rosenberg T., et al. Osteonecrosis of the jaws associated with the use of bisphosphonates: A review of 63 cases. J Oral Maxillofac Surg 62 (2004) 527
33. Adornato M., Morcos I., and Rozanski J. The treatment of bisphosphonate-associated osteonecrosis of the jaws with bone resection and autologous platelet-derived growth factors. JADA 138 (2007) 971
34. Carlson E. Update on bisphosphonate-related osteonecrosis of the jaw treatment strategies and outcomes. J Oral Maxillofac Surg 65 (2007) 15
35. Harper R., and Fung E. Resolution of bisphosphonate-associated osteonecrosis of the mandible: Possible application for intermittent low-dose parathyroid hormone [rhPTH (1-34)]. J Oral Maxillofac Surg 65 (2007) 573
36. Freiberger J., Padilla-Burgos R., Chhoeu A., et al. Hyperbaric oxygen treatment and bisphosphonate-induced osteonecrosis of the jaw: A case series. J Oral Maxillofac Surg 65 (2007) 1321
37. Adornato M., Morcos I., and Rozanski J. The treatment of bisphosphonate-associated osteonecrosis of the jaws with bone resection and autogenous platelet-derived growth factors. JADA 138 (2007) 971
38. Kademani D., Koka S., Lacy M., et al. Primary surgical therapy for osteonecrosis of the jaw secondary to bisphosphonate therapy. Mayo Clin Proc 81 (2006) 1100
39. Mozzo P., Procacci C., Tacconi A., et al. A new volumetric CT machine for dental imaging based on the cone-beam technique: Preliminary results. Eur Radiol 8 (1998) 1558
40. Chiandussi S., Biasotto M., Dore F., et al. Clinical and diagnostic imaging of bisphosphonate-associated osteonecrosis of the jaws. Dento Maxillofac Radiol 35 (2006) 236
41. Harvey B., Ephros H., and DeFalco R. Tetracyline bone labeling in surgical management of chronic osteomyelitis: A case report. J Oral Maxillofac Surg 62 (2004) 752
42. Pautke C., Tischer T., Neff A., et al. In vivo tetracycline labeling of bone: An intraoperative aid in the surgical therapy of osteoradionecrosis of the mandible. Oral Surg Oral Med Oral Path Oral Radiol Endod 102 (2006) e10